A Key Role of microRNA-29b for the Suppression of Colon Cancer Cell Migration by American Ginseng

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Poudyal, Deepak ^a   Cui, Xiangli ^a,b   Le, Phuong Mai ^c   Hofseth, Anne B ^a   Windust, Anthony ^c   Nagarkatti, Mitzi ^d   Nagarkatti, Prakash S ^d   Schetter, Aaron J ^e   Harris, Curtis C ^e   Hofseth, Lorne J ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b SHANXI MEDICAL UNIVERSITY   (China)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^d UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; HEXANE; MICRORNA 29B; PANAX QUINQUEFOLIUS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL MIGRATION; COLON CANCER; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; NONHUMAN; PANAX QUINQUEFOLIUS; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM;

CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; HCT116 CELLS; HUMANS; MATRIX METALLOPROTEINASE 2; MICRORNAS; PANAX; PLANT EXTRACTS;

EID: 84885114390     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075034     Document Type: Article

References (75)

1. Spano D, Heck C, De Antonellis P, Christofori G, Zollo M, (2012) Molecular networks that regulate cancer metastasis. Seminars in Cancer Biology 22: 234-249.
2. Gupta GP, Massague J, (2006) Cancer metastasis: building a framework. Cell 127: 679-695.
3. Yilmaz M, Christofori G, Lehembre F, (2007) Distinct mechanisms of tumor invasion and metastasis. Trends Mol Med 13: 535-541.
4. Brodersen P, Voinnet O, (2009) Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol 10: 141-148.
5. Stark A, Brennecke J, Bushati N, Russell RB, Cohen SM, (2005) Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution. Cell 123: 1133-1146.
6. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101: 2999-3004.
7. Zhang B, Pan X, Cobb GP, Anderson TA, (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12.
8. Cho WC, (2007) OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6: 60.
9. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, et al. (2005) A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
10. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, et al. (2005) RAS is regulated by the let-7 microRNA family. Cell 120: 635-647.
11. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
12. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
13. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436.
14. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
15. Ma L, Teruya-Feldstein J, Weinberg RA, (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688.
16. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, et al. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152.
17. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, et al. (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137: 1032-1046.
18. Chou J, Lin JH, Brenot A, Kim JW, Provot S, et al. (2012) GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. Nat Cell Biol 15: 201-213.
19. Melo SA, Kalluri R, (2012) miR-29b moulds the tumour microenvironment to repress metastasis. Nat Cell Biol 15: 139-140.
20. Fang JH, Zhou HC, Zeng C, Yang J, Liu Y, et al. (2011) MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology 54: 1729-1740.
21. Wang C, Bian Z, Wei D, Zhang JG, (2011) miR-29b regulates migration of human breast cancer cells. Mol Cell Biochem 352: 197-207.
22. Steele R, Mott JL, Ray RB, (2010) MBP-1 upregulates miR-29b that represses Mcl-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells. Genes Cancer 1: 381-387.
23. Garzon R, Heaphy CE, Havelange V, Fabbri M, Volinia S, et al. (2009) MicroRNA 29b functions in acute myeloid leukemia. Blood 114: 5331-5341.
24. Poudyal D, Le PM, Davis T, Hofseth AB, Chumanevich A, et al. (2012) A hexane fraction of American ginseng suppresses mouse colitis and associated colon cancer: anti-inflammatory and proapoptotic mechanisms. Cancer Prev Res (Phila) 5: 685-696.
25. Poudyal D, Cui X, Mai Le P, Davis T, Hofseth AB, et al. (2012) A limited role of p53 on the ability of a Hexane fraction of American ginseng to suppress mouse colitis. J Biomed Biotechnol 2012: 785739.
26. Lee S, Yoo G, Chae H, In M-J, Oh N-S, et al. (2009) Lipid-Soluble Extracts as the Main Source of Anticancer Activity in Ginseng and Ginseng Marc. Journal of the American Oil Chemists' Society 86: 1065-1071.
27. Lee SD, Park SK, Lee ES, Kim HM, Lee CW, et al. (2010) A lipid-soluble red ginseng extract inhibits the growth of human lung tumor xenografts in nude mice. J Med Food 13: 1-5.
28. Matsunaga H, Katano M, Yamamoto H, Fujito H, Mori M, et al. (1990) Cytotoxic activity of polyacetylene compounds in Panax ginseng C. A. Meyer. Chem Pharm Bull (Tokyo) 38: 3480-3482.
29. Kim JY, Lee KW, Kim SH, Wee JJ, Kim YS, et al. (2002) Inhibitory effect of tumor cell proliferation and induction of G2/M cell cycle arrest by panaxytriol. Planta Med 68: 119-122.
30. Jin Y, Kotakadi VS, Ying L, Hofseth AB, Cui X, et al. (2008) American ginseng suppresses inflammation and DNA damage associated with mouse colitis. Carcinogenesis 29: 2351-2359. Epub 2008 Sep 2318.
31. Ying L, Marino J, Hussain SP, Khan MA, You S, et al. (2005) Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation. Cancer Res 65: 9132-9136.
32. Cui X, Jin Y, Poudyal D, Chumanevich AA, Davis T, et al. (2010) Mechanistic insight into the ability of American ginseng to suppress colon cancer associated with colitis. Carcinogenesis 31: 1734-1741.
33. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, et al. (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 104: 15805-15810.
34. Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y, et al. (2010) Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51: 836-845.
35. Amodio N, Di Martino MT, Foresta U, Leone E, Lionetti M, et al. (2012) miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. Cell Death Dis 3: e436.
36. Schmalfeldt B, Prechtel D, Harting K, Spathe K, Rutke S, et al. (2001) Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res 7: 2396-2404.
37. Pesta M, Holubec L Jr, Topolcan O, Cerna M, Rupert K, et al. (2005) Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples. Anticancer Res 25: 3387-3391.
38. Ara T, Fukuzawa M, Kusafuka T, Komoto Y, Oue T, et al. (1998) Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: association with tumor progression and clinical outcome. J Pediatr Surg 33: 1272-1278.
39. Mendes O, Kim HT, Lungu G, Stoica G, (2007) MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2. Clin Exp Metastasis 24: 341-351.
40. Fang J, Shing Y, Wiederschain D, Yan L, Butterfield C, et al. (2000) Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci U S A 97: 3884-3889.
41. Ogawa M, Ikeuchi K, Watanabe M, Etoh K, Kobayashi T, et al. (2005) Expression of matrix metalloproteinase 7, laminin and type IV collagen-associated liver metastasis in human colorectal cancer: immunohistochemical approach. Hepato-Gastroenterology 52: 875-880.
42. Sunami E, Tsuno N, Osada T, Saito S, Kitayama J, et al. (2000) MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist 5: 108-114.
43. Liabakk NB, Talbot I, Smith RA, Wilkinson K, Balkwill F, (1996) Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 56: 190-196.
44. Yamada T, Oshima T, Yoshihara K, Tamura S, Kanazawa A, et al. (2010) Overexpression of MMP-13 gene in colorectal cancer with liver metastasis. Anticancer Res 30: 2693-2699.
45. Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, et al. (2009) MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113: 6411-6418.
46. Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, et al. (2006) Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 66: 11590-11593.
47. Calin GA, Pekarsky Y, Croce CM, (2007) The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract Res Clin Haematol 20: 425-437.
48. Mott JL, Kobayashi S, Bronk SF, Gores GJ, (2007) mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26: 6133-6140.
49. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
50. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, et al. (2007) MicroRNA expression profiling in prostate cancer. Cancer Res 67: 6130-6135.
51. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
52. Kuo TY, Hsi E, Yang IP, Tsai PC, Wang JY, et al. (2012) Computational analysis of mRNA expression profiles identifies microRNA-29a/c as predictor of colorectal cancer early recurrence. PLoS One 7: e31587.
53. Chen KC, Wang YS, Hu CY, Chang WC, Liao YC, et al. (2011) OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J 25: 1718-1728.
54. Liu Y, Taylor NE, Lu L, Usa K, Cowley AW Jr, et al. (2010) Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension 55: 974-982.
55. Sariahmetoglu M, Crawford BD, Leon H, Sawicka J, Li L, et al. (2007) Regulation of matrix metalloproteinase-2 (MMP-2) activity by phosphorylation. FASEB J 21: 2486-2495.
56. Kessenbrock K, Plaks V, Werb Z, (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67.
57. Sternlicht MD, Werb Z, (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516.
58. Egeblad M, Werb Z, (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174.
59. Lynch CC, Matrisian LM, (2002) Matrix metalloproteinases in tumor-host cell communication. Differentiation 70: 561-573.
60. Fingleton B, (2006) Matrix metalloproteinases: roles in cancer and metastasis. Front Biosci 11: 479-491.
61. McCawley LJ, Matrisian LM, (2001) Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol. 13: 534-540.
62. Woessner JF Jr, (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145-2154.
63. Ru P, Steele R, Newhall P, Phillips NJ, Toth K, et al. (2012) miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling. Mol Cancer Ther 11: 1166-1173.
64. Wang CZ, Aung HH, Ni M, Wu JA, Tong R, et al. (2007) Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med 73: 669-674.
65. Jung JS, Kim DH, Kim HS, (2010) Ginsenoside Rh1 suppresses inducible nitric oxide synthase gene expression in IFN-gamma-stimulated microglia via modulation of JAK/STAT and ERK signaling pathways. Biochem Biophys Res Commun 397: 323-328.
66. Cheng CC, Yang SM, Huang CY, Chen JC, Chang WM, et al. (2005) Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother Pharmacol 55: 531-540.
67. Liu WK, Xu SX, Che CT, (2000) Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci 67: 1297-1306.
68. Mochizuki M, Yoo YC, Matsuzawa K, Sato K, Saiki I, et al. (1995) Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull 18: 1197-1202.
69. Fujimoto J, Sakaguchi H, Aoki I, Toyoki H, Khatun S, et al. (2001) Inhibitory effect of ginsenoside-Rb2 on invasiveness of uterine endometrial cancer cells to the basement membrane. Eur J Gynaecol Oncol 22: 339-341.
70. Yoon JH, Choi YJ, Cha SW, Lee SG, (2012) Anti-metastatic effects of ginsenoside Rd via inactivation of MAPK signaling and induction of focal adhesion formation. Phytomedicine 19: 284-292.
71. Wang W, Zhang X, Qin JJ, Voruganti S, Nag SA, et al. (2012) Natural product ginsenoside 25-OCH3-PPD inhibits breast cancer growth and metastasis through down-regulating MDM2. PLoS One 7: e41586.
72. Chan LS, Yue PY, Mak NK, Wong RN, (2009) Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis. Eur J Pharm Sci 38: 370-377.
73. Lu MC, Lai TY, Hwang JM, Chen HT, Chang SH, et al. (2009) Proliferation- and migration-enhancing effects of ginseng and ginsenoside Rg1 through IGF-I- and FGF-2-signaling pathways on RSC96 Schwann cells. Cell Biochem Funct 27: 186-192.
74. Yue PY, Wong DY, Ha WY, Fung MC, Mak NK, et al. (2005) Elucidation of the mechanisms underlying the angiogenic effects of ginsenoside Rg(1) in vivo and in vitro. Angiogenesis 8: 205-216.
75. Park MT, Cha HJ, Jeong JW, Kim SI, Chung HY, et al. (1999) Glucocorticoid receptor-induced down-regulation of MMP-9 by ginseng components, PD and PT contributes to inhibition of the invasive capacity of HT1080 human fibrosarcoma cells. Mol Cells 9: 476-483.